FINX vs. NBDS ETF Comparison
Comparison of Global X FinTech Thematic ETF (FINX) to Neuberger Berman Disrupters ETF (NBDS)
FINX
Global X FinTech Thematic ETF
FINX Description
The Global X FinTech Thematic ETF (FINX) seeks to invest in companies on the leading edge of the emerging financial technology sector, which encompasses a range of innovations helping to transform established industries like insurance, investing, fundraising, and third-party lending through unique mobile and digital solutions
Grade (RS Rating)
Last Trade
$25.78
Average Daily Volume
92,346
Number of Holdings
*
41
* may have additional holdings in another (foreign) market
NBDS
Neuberger Berman Disrupters ETF
NBDS Description
Neuberger Berman Disrupters ETF is an exchange traded fund launched and managed by Neuberger Berman Investment Advisers LLC. It invests in public equity markets of global region. The fund invests in stocks of companies operating across information technology, healthcare, communication services, and consumer discretionary sectors. It invests in growth and value stocks of companies across diversified market capitalization. It invests in stocks of companies that are deemed socially conscious in their business dealings and directly promote environmental responsibility. It employs fundamental analysis with bottom-up stock picking approach to create its portfolio. Neuberger Berman Disrupters ETF is domiciled in the United States.Grade (RS Rating)
Last Trade
$27.69
Average Daily Volume
3,035
Number of Holdings
*
24
* may have additional holdings in another (foreign) market
Performance
Period | FINX | NBDS |
---|---|---|
30 Days | -6.73% | -4.55% |
60 Days | -1.45% | -1.95% |
90 Days | 5.87% | 4.18% |
12 Months | 25.51% | 35.18% |
1 Overlapping Holdings
Symbol | Grade | Weight in FINX | Weight in NBDS | Overlap | |
---|---|---|---|---|---|
INTU | C | 5.89% | 4.2% | 4.2% |
FINX Overweight 40 Positions Relative to NBDS
Symbol | Grade | Weight | |
---|---|---|---|
PYPL | A | 6.61% | |
FIS | B | 6.44% | |
SQ | C | 5.86% | |
COIN | B | 5.4% | |
GPN | C | 4.54% | |
SSNC | C | 4.35% | |
JKHY | D | 3.5% | |
XRX | F | 3.43% | |
TOST | B | 2.87% | |
GWRE | C | 2.69% | |
AFRM | D | 2.45% | |
SOFI | C | 2.13% | |
HQY | C | 1.98% | |
BILL | F | 1.86% | |
STNE | C | 1.28% | |
MARA | D | 1.25% | |
ACIW | A | 1.05% | |
FOUR | F | 1.01% | |
NCNO | F | 0.98% | |
ENV | A | 0.98% | |
AMK | D | 0.75% | |
FLYW | F | 0.74% | |
RIOT | D | 0.7% | |
PAGS | C | 0.69% | |
DLO | F | 0.68% | |
UPST | F | 0.57% | |
VIRT | A | 0.54% | |
SPNS | A | 0.49% | |
VERX | B | 0.48% | |
MLNK | D | 0.39% | |
CIFR | A | 0.35% | |
LMND | B | 0.35% | |
LC | C | 0.26% | |
MITK | B | 0.17% | |
BLND | C | 0.17% | |
LPRO | F | 0.17% | |
IIIV | A | 0.16% | |
TREE | C | 0.14% | |
CTLP | F | 0.13% | |
PAY | B | 0.12% |
FINX Underweight 23 Positions Relative to NBDS
Symbol | Grade | Weight | |
---|---|---|---|
NVDA | B | -7.73% | |
UBER | D | -5.72% | |
AMD | C | -5.02% | |
SWAV | A | -4.84% | |
AMZN | A | -4.66% | |
ASML | C | -4.54% | |
LLY | D | -4.49% | |
TW | C | -4.34% | |
ISRG | C | -4.32% | |
TDG | A | -3.95% | |
ONTO | B | -3.88% | |
MSFT | D | -3.8% | |
NOW | D | -3.48% | |
DKNG | C | -3.42% | |
MPWR | C | -3.34% | |
RMBS | D | -3.1% | |
MDB | C | -2.97% | |
MRNA | B | -2.97% | |
PANW | B | -2.8% | |
KEYS | C | -2.76% | |
DXCM | B | -2.73% | |
IDXX | D | -2.67% | |
PCOR | D | -2.13% |
FINX: Top Represented Industries & Keywords
NBDS: Top Represented Industries & Keywords
Industries:
Software - Application
Semiconductors
Diagnostics & Research
Semiconductor Equipment & Materials
Aerospace & Defense
Biotechnology
Capital Markets
Drug Manufacturers - Major
Gambling
Medical Devices
Medical Instruments & Supplies
Scientific & Technical Instruments
Semiconductor Memory
Software - Infrastructure
Specialty Retail
Keywords:
S&P 500
Nasdaq 100
Computing
Semiconductor
Design Manufacturers
IBD 50
Integrated Circuits
Medicine
Smartphones
Work From Home
Antibiotics
Artificial Intelligence
Cattle
Computer Architecture
Deep Learning
Diabetes
Display Technology
Dow Jones Component
Electronic Engineering
Endocrinology